Targeted siRNA-lactobionic lipid nanoparticles with novel ionizable lipid inhibit antithrombin III expression in hepatocytes
Authors: Rajabi Zangi, Ali; Kiaie, Seyed Hossein; Sajadi, Seyed Milad Safar; Heidari, Hamid Reza; Hamishehkar, Hamed; Javadzadeh, Yousef
Source journal: Discover nano (2026-11-16)
DOI: 10.1186/s11671-026-05012-8
Abstract
Targeted reduction of hepatic antithrombin (AT) via siRNA offers a promising strategy to enhance thrombin (TMB) generation in bleeding disorders, though efficient hepatocyte delivery remains challenging. This study developed and evaluated a targeted lipid nanoparticle (LNP) formulation incorporating a novel morpholine-based ionizable lipid (MIL) and a lactobionic-octadecylamine conjugate (LBN) for hepatocyte-specific delivery of AT-siRNA (siAT). Following synthesis of MIL and LBN, siAT-loaded LNP (siAT LNP LBN) were prepared using microfluidics and characterized for size, morphology, zeta potential, polydispersity index, and encapsulation efficiency (EE). Functional assays on HepG2 cells assessed cellular uptake, protein knockdown, and AT activity. The optimized formulation exhibited uniform particles (124 nm, PDI 0.125, zeta potential - 8.9 mV) and high EE (90%). Cytotoxicity assays confirmed safety up to 65 pmol siRNA. LBN-decorated LNP significantly enhanced hepatocyte uptake compared to non-targeted LNP and naked siRNA. Optimal AT mRNA suppression occurred at ~ 65 pmol siRNA and 16 h, with protein knockdown confirmed at 48 h. Functionally, siAT LNP LBN reduced AT activity to 48.1 +/- 5.5%, substantially outperforming non-targeted LNP (64.1%) and naked siRNA (86.6%). The developed siAT-LNP-LBN platform demonstrated efficient hepatocyte uptake, robust AT knockdown, and low cytotoxicity in vitro, providing preliminary evidence for its potential as a hepatocyte-targeted siRNA delivery platform. Further in vivo studies are warranted to evaluate its biodistribution, liver-targeting efficiency, pharmacodynamic effects, therapeutic efficacy, and biosafety.
Related topics
Related open access articles
- Emerging mycotoxins in botanicals: benefit and risk
- A Brief Review on Core/shell Quantum Dots
- In vitro cytotoxicity studies on galactosylated chitosan nanoparticles for the delivery of oridonin to liver
- Separation of Six Lupane-Type Triterpenoid Saponins from Leaves of Acanthopanax gracilistylus by HSCCC with Preparative-HPLC
- Chemical characterization of polyphenol extracts from Andean and industrial Solanum tuberosum tubers and their cytotoxic activity on human hepatocarcinoma cells
- Effects of Stresses on the Growth and Cytotoxicity of Shiga-Toxin Producing Escherichia coli in Ground Beef and Spinach
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.